News
TipRanks on MSN6h
Genmab’s Cervical Cancer Study: A Potential Game-Changer?
Genmab (Otc) (($GMAB)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1b/2 Open-Label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback